| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 11 insiders with recent SEC Form 4 filings, including 8 buys and 3 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $25.61M | - | |
| CEO | 188.2K | $2.06M | - | |
| Other | 99.2K | $1.08M | - | |
| CFO | 84.2K | $920.0K | - | |
| COO | 54.3K | $593.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Millian Craig Stuart | Chief Operating Officer | Buy | 10,000 | $0.37 | $3,700.00 | +83.3% | -22.9% | -81.2% | |
| Mar 10, 2022 | Moran Sean F.61 | Chief Financial Officer | Buy | 15,000 | $0.37 | $5,550.00 | +9.9% | -22.9% | -81.2% | |
| Mar 9, 2022 | Cohen Yuval65 | Chief Executive Officer | Buy | 8,600 | $0.37 | $3,182.00 | +11.4% | -23.3% | -78.6% | |
| Dec 21, 2020 | Moran Sean F.61 | Chief Financial Officer | Sale+OE | 141,110 | $1.62 | $228,179.00 | -16.8% | - | - | |
| Dec 16, 2020 | Moran Sean F.61 | Chief Financial Officer | Sale+OE | 36,923 | $1.32 | $48,627.59 | -9.6% | - | - | |
| Nov 11, 2020 | Cohen Yuval65 | Chief Executive Officer | Buy | 4,240 | $1.21 | $5,126.16 | +6.0% | - | - | |
| Mar 17, 2020 | Millian Craig Stuart | Chief Commercial Officer | Buy | 2,000 | $4.25 | $8,500.00 | +20.0% | - | - | |
| Mar 17, 2020 | Discordia Robert Paul | Chief Operating Officer | Buy | 2,840 | $3.54 | $10,053.60 | +8.7% | - | - | |
| Mar 17, 2020 | White Barbara | Chief Medical Officer | Buy | 15,606 | $3.63 | $56,649.78 | +8.2% | - | - | |
| Mar 17, 2020 | Cohen Yuval65 | Chief Executive Officer | Buy | 4,300 | $3.49 | $15,007.00 | +6.4% | - | - |